AbCellera Biologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq 8731 https://www.abcellera.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc

AbCellera to Report Second Quarter 2021 Financial Results on August 12, 2021 - Jul 22nd, 2021 8:05 pm
Is AbCellera Biologics Inc. (ABCL) A Good Stock To Buy? - Jul 21st, 2021 2:15 pm
Interested in Investing in Canadian Stocks? Check This Out. - Jul 14th, 2021 9:22 pm
AbCellera Appoints Neil Berkley as Chief Business Officer - Jul 13th, 2021 1:00 pm
Here Are the Best and Worst Biopharma Stock Performers So Far This Year - Jun 30th, 2021 3:32 pm
AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada - Jun 22nd, 2021 1:00 pm
AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares - Jun 10th, 2021 9:11 pm
AbCellera Biologics Inc. (NASDAQ:ABCL) Analysts Just Cut Their EPS Forecasts Substantially - May 16th, 2021 7:02 am
CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results - May 15th, 2021 12:48 am
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug - May 14th, 2021 8:07 pm
AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript - May 14th, 2021 3:30 am
AbCellera to Present Virtually at Berenberg Conference on May 18, 2021 - May 11th, 2021 8:05 pm
AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy - May 6th, 2021 1:00 pm
AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials - May 4th, 2021 1:31 pm
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials - May 4th, 2021 10:30 am
AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals - Apr 29th, 2021 8:10 pm
AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021 - Apr 21st, 2021 8:05 pm
Is ABCL Stock A Buy or Sell? - Apr 20th, 2021 3:37 pm
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split - Apr 15th, 2021 11:49 am
AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration - Apr 14th, 2021 8:05 pm